 |
Neljapäev, 15. juuni 2017
|
| 08:40-09:00 |
Registreerimine |
 |
| 09:00 | KONVERENTSI AVAMINE |
| | Dr. Marco Kirm, Vice-Rector for Research, University of Tartu, Estonia |
| | Dr. Tõnu Esko, Deputy Director for Research, Estonian Genome Center, University of Tartu, Estonia |
|
| 09:15-10:40 |
AVASESSIOON
Big data –path to stratified healthcare (Chair: Dr. Tõnu Esko) |
| | Prof. Mark Caulfield, Genomics of England, UK
Sequencing of 100,000 genomes to improve healthcare services in UK |
| | Dr. Ingrid Borecki, Washington University at St Louis, US
The Path to Translation and Target Development Informed by Human Genetics |
|
| 10:40-10:55 |
Kohvi / tee |
|
| 10:55-12:15 |
I SESSIOON
Big data analytics (Chair: Dr. Reedik Mägi) |
| | Dr. Madis Tiik, SITRA, Finland
Future of EHealth. From Health 1.0 to Health 3.0 |
| | Dr. Frederik Trier Moller, Statens Serum Institute, Denmark
Customer purchase records and health informatics |
|
| 12:15-13:30 |
Lõuna |
|
| 13:30-15:30 |
II SESSIOON
Functional genomics and cellular models (Chair: Dr. Lili Milani) |
| | Dr. Vinod Kumar Magadi Gopalaiah, University of Groningen, The Netherlands
Systems analysis to map regulators of human immune system |
| | Dr. Soeren Lienkamp, Universitätsklinikum Freiburg, Germany
Direct reprogramming of renal tubule cells in the study of genetic kidney disease |
| | Dr. Gregory Michelotti, Metabolon, Inc., US
Genotype to deep phenotype: Metabolon unlocking gene function and biology |
|
| 15:30-15:50 |
Kohvi / tee |
|
| 15:50-17:50 |
III SESSIOON
Mutation pattern in disease and evolution (Chair:Dr. Mait Metspalu) |
| | Dr. Alex Hoischen, Radboud Institute for Molecular Life Sciences; Radboud University Medical Center, The Netherlands
The role and timing of de novo mutations in health and disease |
| | Prof. Laurent Excoffier, University of Bern and Swiss Institute of Bioinformatics, Switzerland
Demographic inference from NGS data: Application to humans and chimpanzees |
| | Dr. Franceso Montinaro, University of Oxford, UK
Complex ancient genetic structure and cultural transitions in southern African populations |
|
| 20:00 | Õhtusöök |
|
|
Reede, 16. juuni 2017
|
| 09:30-11:30 |
IV SESSIOON
Microbiome in health and disease (Chair: Dr. Elin Org) |
| | Prof. Willem de Vos, Wageningen and Helsinki University, Finland
The human intestinal microbiome: From structure to solutions |
| | Prof. Markku Laakso, University of Eastern Finland, Kuopio, Finland
Genetics of metabolic diseases in an isolated population |
| | Prof. Vallo Tillmann, Tartu University Hospital, Estonia
DIABIMMUNE study: what we have learned about the hygiene hypothesis |
|
| 11:30-11:50 |
Kohvi / tee |
|
| 11:50-13:50 |
V SESSIOON
Genomics of brain function and disease (Chair: Prof. Alexandre Reymond) |
| | Dr. Malte Spielmann, University of Washington, Seattle, US
CRISPR-CAS9 genome editing to investigate non-coding mutations |
| | Prof. Phil Koellinger, Vrije Universiteit Amsterdam; Erasmus University Rotterdam Institute for Behavior and Biology, The Netherlands
GWAS results for educational attainment aid in identifying genetic heterogeneity in schizophrenia |
| | Dr. Didier Trono, Ecole Polytechnique Fédérale de Lausanne (EPFL), School of Life Sciences, Lausanne, Switzerland
Transposable elements, their controllers and the uniqueness of human biology |
|
| 13:50-15:00 |
Lõuna |
|
| 15:00-17:00 |
VI SESSIOON
Genomics guided healthcare models (Chair: Prof. Andres Metspalu) |
| | Prof. Paul Hoffmann, Nice Center Hospital (CHU), Nice, France
Next generation biobank in thoracic oncology: Why and how? |
| | Prof. Rando Allikmets, Columbia University Medical Center, US
Simple and complex retinal disease |
| | Prof. Ruth Loos, Icahn School of Medicine at Mount Sinai, New York, NY, US
The genetics of obesity – beyond common variation and common phenotypes |
|
| 17:00 | Konverentsi lõpetamine |
|
